Quick Answer
TENAX THERAPEUTICS, INC. reported Total Assets of $104.23 million for the year ending 2025.
- TENAX THERAPEUTICS, INC. showed an increase of +7.8% in Total Assets from 2024 to 2025.
- This data is from TENAX THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $6.18 million | Q4 2011: $4.55 million | Q1 2012: $5.89 million | Q3 2012: $5.13 million | Q4 2012: $3.54 million | Q1 2013: $3.04 million | Q3 2013: $5.89 million | Q4 2013: $4.36 million | Q1 2014: $33.94 million | Q3 2014: $91.40 million | Q4 2014: $89.22 million | Q1 2015: $86.19 million | Q2 2015: $82.91 million | Q3 2015: $78.59 million | Q4 2015: $75.45 million | Q1 2016: $69.54 million | Q2 2016: $64.13 million | Q3 2016: $59.71 million | Q1 2017: $19.15 million | Q2 2017: $13.45 million | Q3 2017: $11.00 million | Q1 2018: $8.31 million | Q2 2018: $7.03 million | Q3 2018: $5.45 million | Q1 2019: $11.46 million | Q2 2019: $9.66 million | Q3 2019: $7.77 million | Q1 2020: $5.95 million | Q2 2020: $5.35 million | Q3 2020: $9.00 million | Q1 2021: $4.56 million | Q2 2021: $2.89 million | Q3 2021: $8.91 million | Q1 2022: $3.74 million | Q2 2022: $8.36 million | Q3 2022: $4.74 million | Q1 2023: $15.27 million | Q2 2023: $14.05 million | Q3 2023: $11.89 million | Q1 2024: $14.46 million | Q2 2024: $10.62 million | Q3 2024: $99.78 million | Q1 2025: $112.06 million | Q2 2025: $105.86 million | Q3 2025: $102.81 million.
- Over the full 16 years of available data (2011 to 2025), TENAX THERAPEUTICS, INC.'s Total Assets has grown by 3,466.5%.
- Historical annual values: Fiscal year 2025: $104.23 million | Fiscal year 2024: $96.69 million | Fiscal year 2023: $11.69 million | Fiscal year 2022: $3.40 million | Fiscal year 2021: $5.99 million | Fiscal year 2020: $6.87 million | Fiscal year 2019: $6.37 million | Fiscal year 2018: $13.34 million | Fiscal year 2017: $9.89 million | Fiscal year 2016: $23.34 million | Fiscal year 2015: $72.99 million | Fiscal year 2015: $82.91 million | Fiscal year 2014: $93.43 million | Fiscal year 2013: $3.18 million | Fiscal year 2012: $4.14 million | Fiscal year 2011: $2.92 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: